stella
beta
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion — Stella
Recruiting
Back to Acute Leukemia trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
New York Medical College, Valhalla, New York
View full record on ClinicalTrials.gov